Home > News > Multinationals Move on Nanotech
March 28th, 2007
Multinationals Move on Nanotech
All of that should remind investors who once scoured the markets for a hot nanotech play that they may find nanotech-driven profits through multinationals. Not only do these international giants have the deep R&D pockets to sustain investment that might not pan out for years, they long ago built inroads for overseas collaboration.
Nanotech is one area of innovation that is not driven by start-ups -- at least for now. The day may come when a hot new IPO reignites fervor in so-called nanotech stocks. But for the foreseeable future, the next big thing belongs to the same old multinationals.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
'Exotic' material is like a switch when super thin April 18th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014
Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014
Thinnest feasible membrane produced April 17th, 2014